| 0 (0%) | 09-27 11:11 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 28.45 | 1-year : | 33.23 |
| Resists | First : | 24.36 | Second : | 28.45 |
| Pivot price | 24.31 |
|||
| Supports | First : | 24.23 | Second : | 24.15 |
| MAs | MA(5) : | 24.31  |
MA(20) : | 24.3 |
| MA(100) : | 24.2 |
MA(250) : | 24.12 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 64.1 |
D(3) : | 69.6 |
| RSI | RSI(14): 55.4 |
|||
| 52-week | High : | 24.52 | Low : | 23.86 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ IBDS ] has closed below upper band by 47.8%. Bollinger Bands are 49.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 24.35 - 24.49 | 24.49 - 24.62 |
| Low: | 23.93 - 24.11 | 24.11 - 24.28 |
| Close: | 24.06 - 24.32 | 24.32 - 24.56 |
Fri, 26 Sep 2025
Stocks To Watch: Which Companies Are Now Outperforming 95% Of All Stocks? - Investor's Business Daily
Thu, 25 Sep 2025
IBD Drive Time: Jason Schairer, MD, on Extraintestinal Manifestations in IBD - HMP Global Learning Network
Tue, 16 Sep 2025
Can Gut Bacterial Patterns Identify IBD in Kids Without Invasive Tests? - HealthCentral
Fri, 05 Sep 2025
Cedars-Sinai Hosts Women and IBD Symposium Sept. 13 - Cedars-Sinai
Wed, 03 Sep 2025
IBD Elite 2025: Top 10 firms with the fastest growing payouts - financial-planning.com
Mon, 02 Jun 2025
Metabolic modeling reveals a multi-level deregulation of host-microbiome metabolic networks in IBD - Nature
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|